Elite Pharmaceuticals ELTP
OTC ELTP
$0.37 +0.05 (+15.63%)
At close: Nov 16, 2026 · 4:00 PM EST

Elite Pharmaceuticals (ELTP) Invested Capital (2009 - 2026)

Updated

Elite Pharmaceuticals (ELTP) posted Invested Capital of $124.51 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), up 94.5% from $64.02 million a year earlier and up 16.2% from the prior quarter.

Analysis

Elite Pharmaceuticals (ELTP) Invested Capital (2009 - 2026) Analysis & Trends

For FY2026 (ended Mar 31, 2026), Elite Pharmaceuticals' Invested Capital came in at $101.26 million, up 68.8% from FY2025.

  • Annual Invested Capital shows a five-year compound annual growth rate of 41.6% (FY2021 to FY2026).
  • In prior fiscal years, Elite Pharmaceuticals' Invested Capital was $60.01 million in FY2025 (-6.6%), $64.25 million in FY2024 (+102.0%), $31.8 million in FY2023 (+19.0%) and $26.72 million in FY2022 (+50.1%).
  • The fiscal Q2 2027 figure stands as the highest quarterly Invested Capital in data going back to fiscal Q4 2009.
  • On a year-over-year basis, Invested Capital has increased in each of the last five quarters, with growth averaging 42.4% over the last eight quarters.
  • The strongest year-over-year quarter for Invested Capital in the past five years was fiscal Q1 2027, with growth of 113.8%; the weakest was fiscal Q1 2026, with a decline of 22.9%.
  • According to Business Quant data, Invested Capital for the three prior fiscal quarters was $107.19 million (Q1 2027), $101.26 million (Q4 2026) and $82.72 million (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 89.77 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 126.18 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 76.32 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 98.72 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 46.28 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 68.36 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 39.27 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 151.97 Bn
10 Elite Pharmaceuticals 401.23 Mn 274.64 Mn 15.99 Mn 124.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 124.51 Mn
Jun 30, 2026 107.19 Mn
Mar 31, 2026 101.26 Mn
Dec 31, 2025 82.72 Mn
Sep 30, 2025 64.02 Mn
Jun 30, 2025 50.14 Mn
Mar 31, 2025 60.01 Mn
Dec 31, 2024 43.00 Mn
Sep 30, 2024 53.93 Mn
Jun 30, 2024 65.01 Mn
Mar 31, 2024 64.25 Mn
Dec 31, 2023 53.13 Mn
Sep 30, 2023 51.84 Mn
Jun 30, 2023 36.91 Mn
Mar 31, 2023 31.80 Mn
Dec 31, 2022 45.47 Mn
Sep 30, 2022 42.20 Mn
Jun 30, 2022 38.05 Mn
Mar 31, 2022 26.72 Mn
Dec 31, 2021 24.33 Mn
API Access

Elite Pharmaceuticals Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=ELTP&period=max&api_key=YOUR_API_KEY